Anne Dupraz Poiseau, Anne Virginie and Stuart Mudge report on efforts to create legal definitions for human tissue-engineered and cell therapy products.
Anne Dupraz-Poiseau, Anne Virginie, Stuart Mudge
2004 - The Regulatory Affairs Journal
The challenge of regulating human tissue-engineered products in the EU
Anne Dupraz Poiseau, Executive Vice President
She has expertise in and works on the design and implementation of regulatory strategies. Anne manages multidisciplinary teams dedicated to complex and innovative healthcare product development programs, including for regenerative and personalized medicine.
Anne-Virginie Eggimann, Executive Director
She focuses on the development of drugs and biologics services, including for cell and gene therapies. She has expertise in and works on the design and implementation of science‑based regulatory strategies. She manages multidisciplinary teams dedicated to complex and innovative medicinal products development, at all stages, including for personalized medicine.
Stuart Mudge, Senior Consultant Product Development
Stuart's focus was providing regulatory and project management services to a range of clients, typically emerging life science companies seeking to develop their products in the European and USA markets. At all times the goal was to deliver and implement development plans that were compatible with both Europe and the USA.